Cencora (COR) Q1 FY25 earnings call

Cencora delivered a strong Q1 FY25, driven by robust performance in its U.S. Healthcare Solutions segment, particularly from strong utilization trends and GLP-1 product sales, leading to a raised full-year EPS outlook. The company is strategically expanding its specialty leadership through MSO investments like RCA, while navigating headwinds in its international logistics business and managing cash flow timing.